BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10836366)

  • 1. Serum immunoglobulin levels in relation to levels of specific antibodies in allogeneic and autologous bone marrow transplant recipients.
    Hammarström V; Pauksen K; Svensson H; Lönnqvist B; Simonsson B; Ringdén O; Ljungman P
    Transplantation; 2000 Apr; 69(8):1582-6. PubMed ID: 10836366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: the influence of graft versus host reaction.
    Hammarström V; Pauksen K; Azinge J; Oberg G; Ljungman P
    Support Care Cancer; 1993 Jul; 1(4):195-9. PubMed ID: 8193881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients.
    Gandhi MK; Egner W; Sizer L; Inman I; Zambon M; Craig JI; Marcus RE
    Bone Marrow Transplant; 2001 Oct; 28(8):775-81. PubMed ID: 11781630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Titers of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine.
    Giebink GS; Warkentin PI; Ramsay NK; Kersey JH
    J Infect Dis; 1986 Oct; 154(4):590-6. PubMed ID: 3528315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Kinetics of vaccine antibodies to tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococci after allogenic and autologous bone marrow transplantation and booster immunization. 1: The kinetics of vaccine antibodies to tetanus toxoid after allogenic and autologous bone marrow transplantation].
    Prager J; Baumert A; Hermann J; Fuchs D; Zintl F
    Kinderarztl Prax; 1992 Jun; 60(4-5):124-30. PubMed ID: 1495263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary and serum immunoglobulins in recipients of transplanted allogeneic and autologous bone marrow.
    Norhagen G; Engström PE; Björkstrand B; Hammarström L; Smith CI; Ringdén O
    Bone Marrow Transplant; 1994 Aug; 14(2):229-34. PubMed ID: 7994237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation.
    Storek J; Joseph A; Espino G; Dawson MA; Douek DC; Sullivan KM; Flowers ME; Martin P; Mathioudakis G; Nash RA; Storb R; Appelbaum FR; Maloney DG
    Blood; 2001 Dec; 98(13):3505-12. PubMed ID: 11739150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The kinetics of vaccine antibodies against tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococcus after allogeneic and autologous bone marrow transplantation and revaccination. 3: The kinetics of vaccine antibodies against tetanus toxoid and diphtheria toxoid after allogeneic and autologous bone marrow transplantation and combined revaccination against diphtheria and tetanus].
    Prager J; Baumert A; Thilo W; Hermann J; Fuchs D; Sauerbrey A; Zintl F
    Kinderarztl Prax; 1992 Nov; 60(8):230-8. PubMed ID: 1469826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class- and subclass-specific pneumococcal antibody levels and response to immunization after bone marrow transplantation.
    Lortan JE; Vellodi A; Jurges ES; Hugh-Jones K
    Clin Exp Immunol; 1992 Jun; 88(3):512-9. PubMed ID: 1606736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation.
    Avanzini MA; Carra AM; Maccario R; Zecca M; Pignatti P; Marconi M; Comoli P; Bonetti F; De Stefano P; Locatelli F
    J Clin Immunol; 1995 May; 15(3):137-44. PubMed ID: 7559916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetanus immunity in autologous bone marrow and blood stem cell transplant recipients.
    Hammarström V; Pauksen K; Björkstrand B; Simonsson B; Oberg G; Ljungman P
    Bone Marrow Transplant; 1998 Jul; 22(1):67-71. PubMed ID: 9678798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of immunoglobulin isotypes following T-cell depleted allogeneic bone marrow transplantation.
    Brenner MK; Wimperis JZ; Reittie JE; Patterson J; Asherson GL; Hoffbrand AV; Prentice HG
    Br J Haematol; 1986 Sep; 64(1):125-32. PubMed ID: 3530313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation.
    Quinti I; Velardi A; Le Moli S; Guerra E; D'Amelio R; Mastrantonio P; Martelli MF; Aiuti F
    J Clin Immunol; 1990 May; 10(3):160-6. PubMed ID: 2114420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
    Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
    Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some but not all benefits of intravenous immunoglobulin therapy after marrow transplantation appear to correlate with IgG trough levels.
    Cottler-Fox M; Lynch M; Pickle LW; Cahill R; Spitzer TR; Deeg HJ
    Bone Marrow Transplant; 1991 Jul; 8(1):27-33. PubMed ID: 1655138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homogeneous immunoglobulins following allogeneic bone marrow transplantation.
    Hajdu M; Puskás E; Sipos A; Barta A; Pálóczi K; Uher F
    Acta Haematol; 2003; 109(3):124-8. PubMed ID: 12714821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of IgA deficiency after bone marrow transplantation. The influence of acute and chronic graft-versus-host disease.
    Abedi MR; Hammarström L; Ringdén O; Smith CI
    Transplantation; 1990 Sep; 50(3):415-21. PubMed ID: 2402790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic hematopoietic stem cell transplantation recipients have defects of both switched and igm memory B cells.
    D'Orsogna LJ; Wright MP; Krueger RG; McKinnon EJ; Buffery SI; Witt CS; Staples N; Loh R; Cannell PK; Christiansen FT; French MA
    Biol Blood Marrow Transplant; 2009 Jul; 15(7):795-803. PubMed ID: 19539210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum immunoglobulin levels following allogeneic bone marrow transplantation.
    Perreault C; Giasson M; Gyger M; Belanger R; David M; Bonny Y; Boileau J; Barcelo R; Moquin JP
    Blut; 1985 Sep; 51(3):137-42. PubMed ID: 3896351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical changes in sigmoid colon after allogeneic and autologous bone marrow transplantation.
    Forbes GM; Erber WN; Herrmann RP; Davies JM; Collins BJ
    J Clin Pathol; 1995 Apr; 48(4):308-13. PubMed ID: 7615847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.